
Valex CR300 mg
Incepta Pharmaceuticals Ltd.
Sodium Valproate + Valproic Acid is an anticonvulsant (antiepileptic) and mood-stabilizing medicine.
Sodium Valproate + Valproic Acid is an anticonvulsant (antiepileptic) and mood-stabilizing medicine. Its evidence-based uses are classified below.
In patients with multiple seizure types, Sodium Valproate + Valproic Acid is frequently combined with other antiepileptic drugs; dose adjustment of co-administered agents (e.g., lamotrigine) is often required — see Interactions.
Sodium Valproate + Valproic Acid is sometimes used off-label for maintenance treatment of bipolar disorder, for status epilepticus (specific IV valproate formulations), for neuropathic pain, and for agitation in dementia; these uses are not established indications and should only be undertaken under specialist supervision.
| Indication | Typical adult dose |
|---|---|
| Epilepsy (monotherapy or adjunct) | Initial 10–15 mg/kg/day in divided doses, increased at weekly intervals by 5–10 mg/kg/day as needed; usual maintenance 20–60 mg/kg/day (maximum doses vary by seizure type and clinical response). Doses above 250 mg/day are usually given in divided doses. |
| Bipolar disorder (acute mania) | Initial 750 mg/day in divided doses, or 20–30 mg/kg/day as a loading approach in appropriate patients; increase as rapidly as tolerated to the lowest dose producing the desired clinical effect, generally not exceeding 60 mg/kg/day. |
| Migraine prophylaxis | Initial 250 mg twice daily, up to a usual maintenance of 500–1000 mg/day in divided doses. |
For epilepsy in children, dosing is weight-based, generally starting at 10–15 mg/kg/day and titrated to response and tolerability, under specialist supervision, with careful monitoring for hepatotoxicity, especially in children under 2 years (see Contraindications and Precautions and Warnings). Sodium Valproate + Valproic Acid is not indicated for bipolar disorder or migraine prophylaxis in children.
Dose reduction may be needed since a larger fraction of drug remains unbound; monitor free valproate levels and clinical response where feasible.
Sodium Valproate + Valproic Acid is contraindicated in patients with significant hepatic disease or dysfunction — see Contraindications.
Common and serious side effects associated with Sodium Valproate + Valproic Acid include:
Sodium Valproate + Valproic Acid is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.